Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
10.99
+0.51 (4.87%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Ardent Health Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Ardent Health stock has a consensus rating of "Buy" and an average price target of $12.68. The average 1-year stock price forecast is 15.38% higher than the current stock price, while the lowest is $10 (-9.01%) and the highest is $14 (+27.39%).
Price Target: $12.68 (+15.38%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ardent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Maintains $11 → $13 | Hold | Maintains | $11 → $13 | +18.29% | Aug 10, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $9 → $10 | Sell | Reiterates | $9 → $10 | -9.01% | Aug 10, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +18.29% | Aug 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $12 | Hold | Reiterates | $12 | +9.19% | Aug 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +18.29% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
6.46B
from 6.32B
Increased by 2.17%
Revenue Next Year
6.73B
from 6.46B
Increased by 4.13%
EPS This Year
1.09
from 1.54
Decreased by -29.58%
EPS Next Year
1.23
from 1.09
Increased by 12.92%
EPS and Forward PE are based on non-GAAP adjusted numbers.